journal article·2026-04-24

Engineered cells as programmable mRNA delivery vehicles

Felix Horns, Victoria Tobin, Michael B. Elowitz

Nature Reviews Bioengineering· Volume 4· Issue 6
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Pluripotent Stem Cells Research · CRISPR and Genetic Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (15)

Show source-provided references
1. Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. mRNA-based therapeutics: looking beyond COVID-19 vaccines. Lancet 403, 1192–1204 (2024).10.1016/S0140-6736(23)02444-3 ↗
2. Mittelbrunn, M. et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).10.1038/ncomms1285 ↗
3. Pastuzyn, E. D. et al. The neuronal gene Arc encodes a repurposed retrotransposon Gag protein that mediates intercellular RNA transfer. Cell 173, 275–288.e18 (2018).10.1016/j.cell.2018.03.024 ↗
4. Buck, A. H. et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat. Commun. 5, 5488 (2014).10.1038/ncomms6488 ↗
5. Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882–889 (2021).10.1126/science.abg6155 ↗
6. Horns, F. et al. Engineering RNA export for measurement and manipulation of living cells. Cell 186, 3642–3658.e32 (2023).10.1016/j.cell.2023.06.013 ↗
7. O’Brien, K., Breyne, K., Ughetto, S., Laurent, L. C. & Breakefield, X. O. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol. 21, 585–606 (2020).10.1038/s41580-020-0251-y ↗
8. Melenhorst, J. J. et al. Decade-long leukaemia remissions with persistence of CD4 CAR T cells. Nature 602, 503–509 (2022).10.1038/s41586-021-04390-6 ↗
9. Xia, S. et al. Synthetic protein circuits for programmable control of mammalian cell death. Cell 187, 2785–2800.e16 (2024).10.1016/j.cell.2024.03.031 ↗
10. Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61 (2014).10.1016/j.immuni.2014.06.010 ↗
11. Ayala, V. I. et al. CXCR5-dependent entry of CD8 T cells into rhesus macaque B-cell follicles achieved through T-cell engineering. J. Virol. 91, e02507–16 (2017).10.1128/JVI.02507-16 ↗
12. Manhas, J., Edelstein, H. I., Leonard, J. N. & Morsut, L. The evolution of synthetic receptor systems. Nat. Chem. Biol. 18, 244–255 (2022).10.1038/s41589-021-00926-z ↗
13. Arduini, A., Katiyar, H. & Liang, C. Progress in pseudotyping lentiviral vectors towards cell-specific gene delivery in vivo. Viruses 17, 802 (2025).10.3390/v17060802 ↗
14. Qian, Y. et al. Programmable RNA sensing for cell monitoring and manipulation. Nature 610, 713–721 (2022).10.1038/s41586-022-05280-1 ↗
15. Lu, A. C. et al. Engineered protein circuits for cancer therapy. Preprint at bioRxiv https://doi.org/10.1101/2025.04.16.647665 (2025).10.1101/2025.04.16.647665 ↗